Company intelligence / Profile preview

Whole Endo

Malvern, Pennsylvania, United States

Ownership: Private
Development stage: Other

Overview

Endo delivers FDA-approved specialty and generic drugs including innovative therapies for Dupuytren's contracture, pain management, and pediatric endocrinology; the company is also a key supplier of sterile injectables and generics, with commercial-stage assets and legacy brands. The pipeline includes further generics and hospital injectable products, but specifics on current clinical-stage drug development are not disclosed in public sources.[1][2][5][6]

Therapeutic areas: ImmunologyEndocrinologyNephrologyOphthalmologyRheumatologyMen's HealthGastroenterologyPulmonologyOtherNeurology
Modalities: Small moleculeBiologicSterile injectableGenericMonoclonal antibody
Industry: Pharma

Partnerships

Human Growth FoundationMAGIC FoundationPediatric Endocrinology Nursing Society

Beyond the preview

Go deeper on Whole Endo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Whole Endo.

Explore the full profile